PhableCare raised USD25M from Series B Funding, a chronic disease management company based in Bangalore, India.
Kalaari Capital was the lead investor. Participants included Aflac Ventures Digital Horizon, Stride Ventures Omron Ventures SOSV and Fresco Capital.
The company plans to use the funds for further strengthening its full-stack, value-driven chronic care ecosystem, market expansion, customer acquisition (doctors, patients), brand building and creating new revenue streams.
PhableCare, founded by Sumit Sinha (Co-Founder) and Mukesh Bangsal (Founder), is an app-based platform that specializes in chronic disease management. It provides remote consultations, care, timely and intelligent insight, as well as simplified access to healthcare necessities. It has built an ecosystem of care providers, hospitals, medical device manufacturers, health & wellness product manufacturers, e-Pharmacy retailers, and insurance partners bringing digital healthcare to millions of Indians.
Currently 3 Million+ patients and 10k+ doctors and over 1000+ pharmacists use PhableCare’s technology.